mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
SL 0101-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
LAQ824 |
GDSC1000 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.6 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.016 |
0.6 |
mRNA |
Ko-143 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
0.025 |
0.6 |
mRNA |
Tamoxifen |
GDSC1000 |
pan-cancer |
AAC |
-0.019 |
0.6 |